FIELD: chemistry.
SUBSTANCE: invention relates to versions of a compound of formula where R1 is a hydrogen atom; R2 is a lower alkyl group; P is H; , where P1, P2 and P3 are identical or different and are selected from a hydrogen atom, a lower alkyl group and a C14-C22 alkenyl group substituted with a lower alkyl group; or where P1 is an alkenyl group, and each of P2 and P3 is a hydrogen atom; and Y is a C14-C22 alkenyl group with at least one double bond having a Z-configuration, and having a first double bond at the third carbon-carbon bond from the omega (ω)-end of the carbon chain, capable of lowering the level of triglycerides and cholesterol, a pharmaceutical or lipid composition based on the disclosed compounds, as well as use (versions) of the disclosed compounds.
EFFECT: high efficiency of using compounds.
32 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
ALPHA-SUBSTITUTED OMEGA-3 LIPIDS, ACTIVATORS OR MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) | 2007 |
|
RU2507193C2 |
CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
STRUCTURALLY ENHANCED OXYGEN-CONTAINING FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2820995C2 |
CONJUGATES OF FATTY ACIDS AND NIACIN AND APPLICATION THEREOF | 2010 |
|
RU2569063C2 |
FATTY ACID FUMARATE DERIVATIVES AND USES THEREOF | 2011 |
|
RU2588256C2 |
USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 CONTENT | 2015 |
|
RU2705991C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2751770C2 |
COMPOSITIONS OF THE COMPLEXES OF OMEGA-3 FATTY ACIDS | 2013 |
|
RU2633862C2 |
BIOCIDE COMPOSITIONS | 2014 |
|
RU2654110C2 |
CONTAINER WITH IMPROVED GAS BARRIER PROPERTIES | 2006 |
|
RU2434798C2 |
Authors
Dates
2014-03-10—Published
2007-11-01—Filed